Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1
Clinical trial NCT04954001 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04954001
- Sponsor
- Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-26
- Primary completion
- 2025-02-28
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.